| Overexpression of sonic hedgehog in the triple negative breast cancer: clinicopathological characteristics of high burden breast cancer patients from Bangladesh. 6. Noman AS1, Uddin M2, Rahman MZ3, Nayeem MJ1, Alam SS4, Khatun Z1 ... Sci Rep 6, 18830, 2016 | 61 | 2016 |
| Novel ATP‐competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells M Yamaji, A Ota, MD Wahiduzzaman, S Karnan, T Hyodo, H Konishi, ... Cancer medicine 6 (11), 2646-2659, 2017 | 50 | 2017 |
| Tandem paired nicking promotes precise genome editing with scarce interference by p53 T Hyodo, ML Rahman, S Karnan, T Ito, A Toyoda, A Ota, ... Cell reports 30 (4), 1195-1207. e7, 2020 | 42 | 2020 |
| Δ40p53α suppresses tumor cell proliferation and induces cellular senescence in hepatocellular carcinoma cells A Ota, H Nakao, Y Sawada, S Karnan, M Wahiduzzaman, T Inoue, ... Journal of Cell Science 130 (3), 614-625, 2017 | 42 | 2017 |
| Discovery of novel molecular characteristics and cellular biological properties in ameloblastoma S Kondo, A Ota, T Ono, S Karnan, M Wahiduzzaman, T Hyodo, ... Cancer Medicine 9 (8), 2904-2917, 2020 | 28 | 2020 |
| Inhibition of Nox1 induces apoptosis by attenuating the AKT signaling pathway in oral squamous cell carcinoma cell lines K Ito, A Ota, T Ono, T Nakaoka, M Wahiduzzaman, S Karnan, H Konishi, ... Oncology reports 36 (5), 2991-2998, 2016 | 27 | 2016 |
| Improved methods of AAV-mediated gene targeting for human cell lines using ribosome-skipping 2A peptide S Karnan, A Ota, Y Konishi, M Wahiduzzaman, Y Hosokawa, H Konishi Nucleic Acids Research 44 (6), e54-e54, 2016 | 20 | 2016 |
| Novel combined Ato-C treatment synergistically suppresses proliferation of Bcr-Abl-positive leukemic cells in vitro and in vivo MD Wahiduzzaman, A Ota, S Karnan, I Hanamura, S Mizuno, J Kanasugi, ... Cancer Letters 433, 117-130, 2018 | 17 | 2018 |
| Biallelic loss of FAM46C triggers tumor growth with concomitant activation of Akt signaling in multiple myeloma cells J Kanasugi, I Hanamura, A Ota, S Karnan, VQ Lam, S Mizuno, ... Cancer Science 111 (5), 1663-1675, 2020 | 15 | 2020 |
| Establishment and characterization of CRISPR/Cas9‐mediated NF2−/− human mesothelial cell line: Molecular insight into fibroblast growth factor receptor 2 in … M Wahiduzzaman, S Karnan, A Ota, I Hanamura, H Murakami, A Inoko, ... Cancer Science 110 (1), 180-193, 2019 | 13 | 2019 |
| Novel interleukin-6 inducible gene PDZ-binding kinase promotes tumor growth of multiple myeloma cells A Ota, I Hanamura, S Karnan, S Inaguma, N Takei, VQ Lam, S Mizuno, ... Journal of Interferon & Cytokine Research 40 (8), 389-405, 2020 | 12 | 2020 |
| Identification of CD24 as a potential diagnostic and therapeutic target for malignant pleural mesothelioma S Karnan, A Ota, H Murakami, ML Rahman, MN Hasan, M Wahiduzzaman, ... Cell death discovery 6 (1), 127, 2020 | 11 | 2020 |
| CD52 is a novel target for the treatment of FLT3-ITD-mutated myeloid leukemia S Karnan, I Hanamura, A Ota, S Takasugi, A Nakamura, M Takahashi, ... Cell Death Discovery 7 (1), 121, 2021 | 10 | 2021 |
| Novel mechanistic insights into the anti-cancer mode of arsenic trioxide M Wahiduzzaman, A Ota, Y Hosokawa Current cancer drug targets 20 (2), 115-129, 2020 | 10 | 2020 |
| Adiponectin: a promising target for the treatment of diabetes and its complications M Begum, M Choubey, MB Tirumalasetty, S Arbee, MM Mohib, ... Life 13 (11), 2213, 2023 | 9 | 2023 |
| Experimental strategies to achieve efficient targeted knock-in via tandem paired nicking ML Rahman, T Hyodo, S Karnan, A Ota, MN Hasan, Y Mihara, ... Scientific Reports 11 (1), 22627, 2021 | 6 | 2021 |
| Arsenic-based anticancer-combined therapy: novel mechanism inducing apoptosis of cancer cells A Ota, M Wahiduzzaman, Y Hosokawa Current Understanding of Apoptosis-Programmed Cell Death, 2018 | 5 | 2018 |
| The Potent Potential of Green Tea In against Cardiac Disorders: A Comprehensive Review of Recent Discoveries S Akter, M Choubey, S Arbee, MM Mohib, MB Tirumalasetty, A Akhtar, ... Preprints, 2023 | 1 | 2023 |
| CAMK2D: a novel molecular target for BAP1-deficient malignant mesothelioma S Karnan, A Ota, H Murakami, ML Rahman, M Wahiduzzaman, MN Hasan, ... Cell Death Discovery 9 (1), 257, 2023 | 1 | 2023 |
| Toxicity of arsenicals in diseases: friend or foe? E Hossain, M Wahiduzzaman, A Ota Toxicological Risk Assessment and Multi-System Health Impacts from Exposure …, 2021 | 1 | 2021 |
